In this study, we demonstrated another important pathway for conferring resistance to cell death in papillary and anaplastic thyroid cancer cells with the BRAF V600E mutation. The gene discussed is BRAF; the disease is thyroid gland undifferentiated (anaplastic) carcinoma.